Table 5 Laboratory findings of patients between RMPP combined with PB group and RMPP group in the validation dataset
Laboratory information | Patients (n = 173) | RMPP combined with PB (n = 53) | RMPP (n = 120) | P |
|---|---|---|---|---|
WBC (× 109/L) | 7.1 (5.6–9.6) | 7.5 (5.8–9.3) | 7.5 (5.9–9.5) | 0.552 |
N% | 66.3 (57.5–74.2) | 70.5 (65.0–78.2) | 66.7 (56.7–72.9) | 0.000 |
L% | 23.9 (17.1–32.2) | 20.0 (15.0–25.0) | 24.4 (17.5–32.4) | 0.003 |
PLT (× 109/L) | 271.0 (221.0–343.0) | 249.5 (205.8–310.0) | 280.0 (232.0–358.8) | 0.005 |
ESR (mm/h) | 27.0 (21.0–37.0) | 29.0 (22.0–41.0) | 29.0 (22.0–40.0) | 0.567 |
CRP (mg/L) | 25.4 (15.7–46.6) | 32.5 (18.0–58.6) | 22.5 (8.9–38.9) | 0.000 |
PCT (ng/mL) | 0.14 (0.08–0.30) | 0.30 (0.10–0.60) | 0.12 (0.07–0.24) | 0.000 |
IL-6 (pg/mL) | 25.0 (14.5–48.4) | 43.5 (27.1–78.2) | 22.2 (14.1–38.4) | 0.000 |
La (mol/L) | 2.6 (2.1–3.3) | 2.5 (2.1–3.1) | 2.6 (2.1–3.2) | 0.157 |
AST (U/L) | 32.0 (25.0–41.0 | 39.0 (29.0–59.0) | 30.0 (23.0–39.0) | 0.000 |
ALT (U/L) | 14.0 (10.0–27.0) | 16.0 (12.0–28.3) | 14.0 (11.0–20.0) | 0.000 |
CK (U/L) | 103.0 (58.0–197.5) | 126.0 (74.8–244.3) | 91.0 (64.0–144.5) | 0.001 |
CKMB (U/L) | 4.0 (3.0–5.0) | 4.0 (3.0–4.0) | 4.0 (4.0–4.0) | 0.106 |
LDH (U/L) | 404.0 (323.0–551.0) | 482.0 (375.5–630.3) | 389.0 (310.5–505.5) | 0.000 |
FER (ng/L) | 151.1 (106.4–252.6) | 131.8 (74.3–254.7) | 130.2 (95.0–195.4) | 0.326 |
APTT (S) | 30.6 (26.7–34.8) | 30.1 (26.1–34.1) | 29.2 (26.4–32.6) | 0.090 |
FG (g/L) | 4.0 (3.4–4.4) | 4.2 (3.7–4.6) | 4.0 (3.6–4.5) | 0.064 |
D-dimer (mg/L) | 0.2 (0.1–0.5) | 0.2 (0.1–0.6) | 0.1 (0.1–0.3) | 0.000 |
IgE (IU/L) | 122.3 (48.2–285.0) | 108.0 (39.0–252.3) | 89.8 (40.2–221.6) | 0.630 |